Climacteric This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Clinical practice: guidelines, position statements, recommendations and tool kits
Climacteric. 2023 Dec;26(6):515-516. doi: 10.1080/13697137.2023.2266255. Epub 2023 Dec 1.NO ABSTRACTPMID:38039191 | DOI:10.1080/13697137.2023.2266255 (Source: Climacteric)
Source: Climacteric - December 1, 2023 Category: Geriatrics Authors: Rod Baber Source Type: research

Professor Linda Cardozo OBE MB ChB MD FRCOG: 15.09.50-21.09.23
Climacteric. 2023 Dec;26(6):632-633. doi: 10.1080/13697137.2023.2274189. Epub 2023 Dec 1.NO ABSTRACTPMID:37997744 | DOI:10.1080/13697137.2023.2274189 (Source: Climacteric)
Source: Climacteric - November 24, 2023 Category: Geriatrics Authors: Dudley Robinson Tim Hillard Source Type: research

Professor Linda Cardozo OBE MB ChB MD FRCOG: 15.09.50-21.09.23
Climacteric. 2023 Nov 24:1-2. doi: 10.1080/13697137.2023.2274189. Online ahead of print.NO ABSTRACTPMID:37997744 | DOI:10.1080/13697137.2023.2274189 (Source: Climacteric)
Source: Climacteric - November 24, 2023 Category: Geriatrics Authors: Dudley Robinson Tim Hillard Source Type: research

Perimenopause in women with rheumatologic diseases: a spotlight on an under-addressed transition
Climacteric. 2023 Nov 22:1-7. doi: 10.1080/13697137.2023.2276201. Online ahead of print.ABSTRACTAbundant research has been published describing the effects invoked during menopause across different organ systems. Changing levels of estrogen and progesterone result in bidirectional alterations of immune cell pathways. Overall, the net trend dampens immunoregulation and promotes inflammation. In paradigmatic rheumatologic diseases, the combined effect is far from predictable. While some features may abate during menopause, studies have shown a general increased frequency toward disease exacerbation. Similarly, while impossib...
Source: Climacteric - November 22, 2023 Category: Geriatrics Authors: J Ben Shimol Source Type: research

Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women
CONCLUSION: In menopausal women, all MHT including conventional-dose EPT, ET and tibolone tended to lower the incidence of fractures. The effects, however, varied with the type of fracture and type of MHT.PMID:37947171 | DOI:10.1080/13697137.2023.2273528 (Source: Climacteric)
Source: Climacteric - November 10, 2023 Category: Geriatrics Authors: H Kim M J Kang J K Baek J K Lee E A Choi B H Yun E H Kim S K Seo Source Type: research